Kalaris Therapeutics, Inc. - KLRS
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Mar 23, 2026 | Chief Accounting Officer | A | A | 60,800.0 | 0.0 | 0.0 | 60,800.0 | View | |
| Mar 23, 2026 | Chief Accounting Officer | S | D | 1,915.0 | 6.72 | 12,868.8 | 0.0 | View | |
| Mar 20, 2026 | Chief Medical Officer | A | A | 135,000.0 | 0.0 | 0.0 | 135,000.0 | View | |
| Mar 20, 2026 | Chief Financial Officer | A | A | 95,000.0 | 0.0 | 0.0 | 95,000.0 | View | |
| Mar 20, 2026 | See Remarks | A | A | 222,000.0 | 0.0 | 0.0 | 222,000.0 | View | |
| Feb 17, 2026 | — | P | A | 479,847.0 | 10.42 | 5,000,005.74 | 1,979,847.0 | View | |
| Dec 22, 2025 | — | A | A | 1,500,000.0 | 10.0 | 15,000,000.0 | 1,500,000.0 | View | |
| Nov 03, 2025 | Chief Financial Officer | A | A | 235,000.0 | 0.0 | 0.0 | 235,000.0 | View |